{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:41:44Z","timestamp":1793410904882,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2014-2020.4.01.15-0012"],"award-info":[{"award-number":["2014-2020.4.01.15-0012"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Estonian Research Foundation","award":["IUT 20-41"],"award-info":[{"award-number":["IUT 20-41"]}]},{"name":"Estonian Research Foundation","award":["IUT 20-42"],"award-info":[{"award-number":["IUT 20-42"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00406-018-0971-6","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T06:36:00Z","timestamp":1546410960000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-0627","authenticated-orcid":false,"given":"Liisa","family":"Leppik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madis","family":"Parksepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Janno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Koido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liina","family":"Haring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Vasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihkel","family":"Zilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"key":"971_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881114563634","volume":"29","author":"O Howes","year":"2015","unstructured":"Howes O, McCutcheon R, Stone J (2015) Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol (Oxf) 29:97\u2013115. https:\/\/doi.org\/10.1177\/0269881114563634","journal-title":"J Psychopharmacol (Oxf)"},{"key":"971_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","volume":"155","author":"R Upthegrove","year":"2014","unstructured":"Upthegrove R, Manzanares-Teson N, Barnes NM (2014) Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 155:101\u2013108. https:\/\/doi.org\/10.1016\/j.schres.2014.03.005","journal-title":"Schizophr Res"},{"key":"971_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/ijnp\/pyx015","volume":"20","author":"D Fraguas","year":"2017","unstructured":"Fraguas D, D\u00edaz-Caneja CM, Rodr\u00edguez-Quiroga A, Arango C (2017) Oxidative stress and inflammation in early onset first episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol 20:435\u2013444. https:\/\/doi.org\/10.1093\/ijnp\/pyx015","journal-title":"Int J Neuropsychopharmacol"},{"key":"971_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","volume":"74","author":"T Pillinger","year":"2017","unstructured":"Pillinger T, Beck K, Gobjila C, Donocik JG, Jauhar S, Howes OD (2017) Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry 74:261\u2013269. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.3803","journal-title":"JAMA Psychiatry"},{"key":"971_CR5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neubiorev.2016.06.002","volume":"76","author":"M Schneider","year":"2017","unstructured":"Schneider M, Levant B, Reichel M, Gulbins E, Kornhuber J, M\u00fcller CP (2017) Lipids in psychiatric disorders and preventive medicine. Neurosci Biobehav Rev 76:336\u2013362. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.06.002","journal-title":"Neurosci Biobehav Rev"},{"key":"971_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","volume":"13","author":"DF Horrobin","year":"1994","unstructured":"Horrobin DF, Glen AIM, Vaddadi K (1994) The membrane hypothesis of schizophrenia. Schizophr Res 13:195\u2013207. https:\/\/doi.org\/10.1016\/0920-9964(94)90043-4","journal-title":"Schizophr Res"},{"key":"971_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00216-012-6117-1","volume":"404","author":"A Zhang","year":"2012","unstructured":"Zhang A, Sun H, Wang X (2012) Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 404:1239\u20131245. https:\/\/doi.org\/10.1007\/s00216-012-6117-1","journal-title":"Anal Bioanal Chem"},{"key":"971_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/9781119085263","volume-title":"Lipidomics: comprehensive mass spectrometry of lipids","author":"X Han","year":"2016","unstructured":"Han X (2016) Lipidomics: comprehensive mass spectrometry of lipids. Wiley, Hoboken"},{"key":"971_CR9","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1021\/acs.jproteome.7b00279","volume":"16","author":"K Kriisa","year":"2017","unstructured":"Kriisa K, Leppik L, Bal\u00f5t\u0161ev R, Ottas A, Soomets U, Koido K, Volke V, Innos J, Haring L, Vasar E, Zilmer M (2017) Profiling of acylcarnitines in first episode psychosis before and after antipsychotic treatment. J Proteome Res 16:3558\u20133566. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00279","journal-title":"J Proteome Res"},{"key":"971_CR10","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","volume":"129","author":"C Stegemann","year":"2014","unstructured":"Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, Menni C, Moayyeri A, Santer P, Rungger G, Spector TD, Willeit J, Kiechl S, Mayr M (2014) Lipidomics profiling and risk of cardiovascular disease in the prospective population-based bruneck study. Circulation 129:1821\u20131831. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002500","journal-title":"Circulation"},{"key":"971_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.numecd.2017.07.011","volume":"28","author":"K Paapstel","year":"2018","unstructured":"Paapstel K, Kals J, Eha J, Tootsi K, Ottas A, Piir A, Jakobson M, Lieberg J, Zilmer M (2018) Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis. Nutr Metab Cardiovasc Dis 28:44\u201352. https:\/\/doi.org\/10.1016\/j.numecd.2017.07.011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"971_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085724","author":"A Sigruener","year":"2014","unstructured":"Sigruener A, Kleber ME, Heimerl S, Liebisch G, Schmitz G, Maerz W (2014) Glycerophospholipid and sphingolipid species and mortality: the ludwigshafen risk and cardiovascular health (LURIC) study. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0085724","journal-title":"PLoS One"},{"key":"971_CR13","doi-asserted-by":"publisher","first-page":"30728","DOI":"10.1074\/jbc.M703745200","volume":"282","author":"K Kanno","year":"2007","unstructured":"Kanno K, Wu MK, Agate DS, Fanelli BJ, Wagle N, Scapa EF, Ukomadu C, Cohen DE (2007) Interacting proteins dictate function of the minimal start domain phosphatidylcholine transfer protein\/starD2. J Biol Chem 282:30728\u201330736. https:\/\/doi.org\/10.1074\/jbc.M703745200","journal-title":"J Biol Chem"},{"key":"971_CR14","unstructured":"Lipid Library website (2009)\u00a0 https:\/\/web.archive.org\/web\/20090531115217\/http:\/\/www.lipidlibrary.co.uk\/Lipids\/pc\/index.htm . Accessed 27 Apr 2018"},{"key":"971_CR15","doi-asserted-by":"publisher","first-page":"e0135228","DOI":"10.1371\/journal.pone.0135228","volume":"10","author":"JY Park","year":"2015","unstructured":"Park JY, Lee S-H, Shin M-J, Hwang G-S (2015) Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction. PLoS One 10:e0135228. https:\/\/doi.org\/10.1371\/journal.pone.0135228","journal-title":"PLoS One"},{"key":"971_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.biopsych.2004.03.019","volume":"56","author":"A Schmitt","year":"2004","unstructured":"Schmitt A, Wilczek K, Blennow K, Maras A, Jatzko A, Petroianu G, Braus DF, Gattaz WF (2004) Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry 56:41\u201345. https:\/\/doi.org\/10.1016\/j.biopsych.2004.03.019","journal-title":"Biol Psychiatry"},{"key":"971_CR17","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1021\/pr800188y","volume":"7","author":"E Schwarz","year":"2008","unstructured":"Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, McKenna P, Bahn S (2008) High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res 7:4266\u20134277. https:\/\/doi.org\/10.1021\/pr800188y","journal-title":"J Proteome Res"},{"key":"971_CR18","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/tp.2012.76","volume":"2","author":"Y He","year":"2012","unstructured":"He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D (2012) Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry 2:e149. https:\/\/doi.org\/10.1038\/tp.2012.76","journal-title":"Transl Psychiatry"},{"key":"971_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.pscychresns.2013.06.011","volume":"214","author":"W Weber-Fahr","year":"2013","unstructured":"Weber-Fahr W, Englisch S, Esser A, Tunc-Skarka N, Meyer-Lindenberg A, Ende G, Zink M (2013) Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study. Psychiatry Res Neuroimaging 214:365\u2013373. https:\/\/doi.org\/10.1016\/j.pscychresns.2013.06.011","journal-title":"Psychiatry Res Neuroimaging"},{"key":"971_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jpsychires.2017.08.009","volume":"95","author":"S Ghosh","year":"2017","unstructured":"Ghosh S, Dyer RA, Beasley CL (2017) Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia. J Psychiatr Res 95:135\u2013142. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.08.009","journal-title":"J Psychiatr Res"},{"key":"971_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00209","author":"A Aquino","year":"2018","unstructured":"Aquino A, Alexandrino GL, Guest PC, Augusto F, Gomes AF, Murgu M, Steiner J, Martins-de-Souza D (2018) Blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2018.00209","journal-title":"Front Psychiatry"},{"key":"971_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/gm233","volume":"3","author":"M Ore\u0161i\u010d","year":"2011","unstructured":"Ore\u0161i\u010d M, Tang J, Sepp\u00e4nen-Laakso T, Mattila I, Saarni SE, Saarni SI, L\u00f6nnqvist J, Sysi-Aho M, Hy\u00f6tyl\u00e4inen T, Per\u00e4l\u00e4 J, Suvisaari J (2011) Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med 3:19. https:\/\/doi.org\/10.1186\/gm233","journal-title":"Genome Med"},{"key":"971_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/mp.2011.131","volume":"18","author":"J Yang","year":"2013","unstructured":"Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C (2013) Potential metabolite markers of schizophrenia. Mol Psychiatry 18:67\u201378. https:\/\/doi.org\/10.1038\/mp.2011.131","journal-title":"Mol Psychiatry"},{"key":"971_CR24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/ajp.156.8.1205","volume":"4","author":"H Fukuzako","year":"1999","unstructured":"Fukuzako H, Kodama S (1999) Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. Am J Psychiatry 4:1205\u20131208","journal-title":"Am J Psychiatry"},{"key":"971_CR25","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00216-011-4909-3","volume":"400","author":"J Matsumoto","year":"2011","unstructured":"Matsumoto J, Sugiura Y, Yuki D, Hayasaka T, Goto-Inoue N, Zaima N, Kunii Y, Wada A, Yang Q, Nishiura K, Akatsu H, Hori A, Hashizume Y, Yamamoto T, Ikemoto K, Setou M, Niwa S (2011) Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption\/ionization imaging mass spectrometry. Anal Bioanal Chem 400:1933. https:\/\/doi.org\/10.1007\/s00216-011-4909-3","journal-title":"Anal Bioanal Chem"},{"key":"971_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jnr.21822","volume":"87","author":"S Narayan","year":"2009","unstructured":"Narayan S, Head SR, Gilmartin TJ, Dean B, Thomas EA (2009) Evidence for disruption of sphingolipid metabolism in schizophrenia. J Neurosci Res 87:278\u2013288. https:\/\/doi.org\/10.1002\/jnr.21822","journal-title":"J Neurosci Res"},{"key":"971_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/mp.2008.86","volume":"14","author":"T Rietkerk","year":"2009","unstructured":"Rietkerk T, Boks MPM, Sommer IEC, Jong S de, Kahn RS, Ophoff RA (2009) Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways. Mol Psychiatry 14:353\u2013355. https:\/\/doi.org\/10.1038\/mp.2008.86","journal-title":"Mol Psychiatry"},{"key":"971_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.psychres.2012.02.019","volume":"198","author":"R Kaddurah-Daouk","year":"2012","unstructured":"Kaddurah-Daouk R, McEvoy J, Baillie R, Zhu H, Yao KJ, Nimgaonkar VL, Buckley PF, Keshavan MS, Georgiades A, Nasrallah HA (2012) Impaired plasmalogens in patients with schizophrenia. Psychiatry Res 198:347\u2013352. https:\/\/doi.org\/10.1016\/j.psychres.2012.02.019","journal-title":"Psychiatry Res"},{"key":"971_CR29","doi-asserted-by":"publisher","first-page":"e68717","DOI":"10.1371\/journal.pone.0068717","volume":"8","author":"J McEvoy","year":"2013","unstructured":"McEvoy J, Baillie RA, Zhu H, Buckley P, Keshavan MS, Nasrallah HA, Dougherty GG, Yao JK, Kaddurah-Daouk R (2013) Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. PLoS One 8:e68717. https:\/\/doi.org\/10.1371\/journal.pone.0068717","journal-title":"PLoS One"},{"key":"971_CR30","doi-asserted-by":"publisher","first-page":"e951","DOI":"10.1038\/tp.2016.222","volume":"6","author":"T Suvitaival","year":"2016","unstructured":"Suvitaival T, Mantere O, Kiesepp\u00e4 T, Mattila I, P\u00f6h\u00f6 P, Hy\u00f6tyl\u00e4inen T, Suvisaari J, Ore\u0161i\u010d M (2016) Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis. Transl Psychiatry 6:e951. https:\/\/doi.org\/10.1038\/tp.2016.222","journal-title":"Transl Psychiatry"},{"key":"971_CR31","doi-asserted-by":"publisher","first-page":"e1240","DOI":"10.1038\/tp.2017.211","volume":"7","author":"A O\u2019Gorman","year":"2017","unstructured":"O\u2019Gorman A, Suvitaival T, Ahonen L, Cannon M, Zammit S, Lewis G, Roche HM, Mattila I, Hyotylainen T, Oresic M, Brennan L, Cotter DR (2017) Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. Transl Psychiatry 7:e1240. https:\/\/doi.org\/10.1038\/tp.2017.211","journal-title":"Transl Psychiatry"},{"key":"971_CR32","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2014.14037","author":"M Philippova","year":"2014","unstructured":"Philippova M, Resink T, Erne P, Bochkov V (2014) Oxidised phospholipids as biomarkers in human disease. Swiss Med Wkly. https:\/\/doi.org\/10.4414\/smw.2014.14037","journal-title":"Swiss Med Wkly"},{"key":"971_CR33","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992","unstructured":"World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva"},{"key":"971_CR34","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O\u2019Donnell H, Centorrino F, Baldessarini RJ (2010) International consensus study of antipsychotic dosing. Am J Psychiatry 167:686\u2013693. https:\/\/doi.org\/10.1176\/appi.ajp.2009.09060802","journal-title":"Am J Psychiatry"},{"key":"971_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.schres.2015.08.027","volume":"169","author":"L Haring","year":"2015","unstructured":"Haring L, Koido K, Vasar V, Leping V, Zilmer K, Zilmer M, Vasar E (2015) Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index. Schizophr Res 169:22\u201329. https:\/\/doi.org\/10.1016\/j.schres.2015.08.027","journal-title":"Schizophr Res"},{"key":"971_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12457","author":"R Bal\u00f5t\u0161ev","year":"2017","unstructured":"Bal\u00f5t\u0161ev R, Haring L, Koido K, Leping V, Kriisa K, Zilmer M, Vasar V, Piir A, Lang A, Vasar E (2017) Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: a 7-month follow-up study. Early Interv Psychiatry. https:\/\/doi.org\/10.1111\/eip.12457","journal-title":"Early Interv Psychiatry"},{"key":"971_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00155","author":"L Leppik","year":"2018","unstructured":"Leppik L, Kriisa K, Koido K, Koch K, Kajalaid K, Haring L, Vasar E, Zilmer M (2018) Profiling of amino acids and their derivatives biogenic amines before and after antipsychotic treatment in first-episode psychosis. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2018.00155","journal-title":"Front Psychiatry"},{"key":"971_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799\u2013812. https:\/\/doi.org\/10.2466\/pr0.1962.10.3.799","journal-title":"Psychol Rep"},{"key":"971_CR39","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd\u00a0edn. L. Erlbaum Associates, Hillsdale","edition":"2"},{"key":"971_CR40","first-page":"401","volume":"31","author":"DW Nordstokke","year":"2010","unstructured":"Nordstokke DW, Zumbo BD (2010) A new nonparametric levene test for equal variances. Psicol Int J Methodol Exp Psychol 31:401\u2013430","journal-title":"Psicol Int J Methodol Exp Psychol"},{"key":"971_CR41","volume-title":"Statistica (data analysis software system), version 13","author":"TIBCO Software Inc","year":"2017","unstructured":"TIBCO Software Inc (2017) Statistica (data analysis software system), version 13. TIBCO Software Inc., Palo Alto"},{"key":"971_CR42","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/oby.21448","volume":"24","author":"KT Tonks","year":"2016","unstructured":"Tonks KT, Coster AC, Christopher MJ, Chaudhuri R, Xu A, Gagnon-Bartsch J, Chisholm DJ, James DE, Meikle PJ, Greenfield JR, Samocha-Bonet D (2016) Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight\/obesity in humans. Obesity 24:908\u2013916. https:\/\/doi.org\/10.1002\/oby.21448","journal-title":"Obesity"},{"key":"971_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00038","author":"V Chiurchi\u00f9","year":"2018","unstructured":"Chiurchi\u00f9 V, Leuti A, Maccarrone M (2018) Bioactive lipids and chronic inflammation: managing the fire within. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00038","journal-title":"Front Immunol"},{"key":"971_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/15622975.2015.1117656","volume":"18","author":"S Sethi","year":"2017","unstructured":"Sethi S, Hayashi MA, Sussulini A, Tasic L, Brietzke E (2017) Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders. World J Biol Psychiatry 18:506\u2013520. https:\/\/doi.org\/10.3109\/15622975.2015.1117656","journal-title":"World J Biol Psychiatry"},{"key":"971_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2008.174","volume":"34","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KRR (2009) Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34:173\u2013186. https:\/\/doi.org\/10.1038\/npp.2008.174","journal-title":"Neuropsychopharmacology"},{"key":"971_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.schres.2017.03.031","volume":"190","author":"B Misiak","year":"2017","unstructured":"Misiak B, Sta\u0144czykiewicz B, \u0141aczma\u0144ski \u0141, Frydecka D (2017) Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: a systematic review and meta-analysis. Schizophr Res 190:18\u201327. https:\/\/doi.org\/10.1016\/j.schres.2017.03.031","journal-title":"Schizophr Res"},{"key":"971_CR47","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1476-5381.2012.02213.x","volume":"168","author":"JE Carland","year":"2013","unstructured":"Carland JE, Mansfield RE, Ryan RM, Vandenberg RJ (2013) Oleoyl-l-carnitine inhibits glycine transport by GlyT2. Br J Pharmacol 168:891\u2013902. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02213.x","journal-title":"Br J Pharmacol"},{"key":"971_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-800892-8.00003-8","volume-title":"Genetic diagnosis of endocrine disorders","author":"D Koren","year":"2016","unstructured":"Koren D, Palladino A (2016) Chap. 3\u2014hypoglycemia. In: Weiss RE, Refetoff S (eds) Genetic diagnosis of endocrine disorders, 2nd\u00a0edn. Academic Press, San Diego, pp\u00a031\u201375","edition":"2"},{"key":"971_CR49","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1038\/nutd.2014.38","volume":"4","author":"H Hanamatsu","year":"2014","unstructured":"Hanamatsu H, Ohnishi S, Sakai S, Yuyama K, Mitsutake S, Takeda H, Hashino S, Igarashi Y (2014) Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults. Nutr Diabetes 4:e141. https:\/\/doi.org\/10.1038\/nutd.2014.38","journal-title":"Nutr Diabetes"},{"key":"971_CR50","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN Veen van der","year":"2017","unstructured":"van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL (2017) The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta BBA Biomembr 1859:1558\u20131572. https:\/\/doi.org\/10.1016\/j.bbamem.2017.04.006","journal-title":"Biochim Biophys Acta BBA Biomembr"},{"key":"971_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.plipres.2017.01.002","volume":"66","author":"S Rodriguez-Cuenca","year":"2017","unstructured":"Rodriguez-Cuenca S, Pellegrinelli V, Campbell M, Oresic M, Vidal-Puig A (2017) Sphingolipids and glycerophospholipids\u2014the \u201cying and yang\u201d of lipotoxicity in metabolic diseases. Prog Lipid Res 66:14\u201329. https:\/\/doi.org\/10.1016\/j.plipres.2017.01.002","journal-title":"Prog Lipid Res"},{"key":"971_CR52","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11306-009-0174-2","volume":"5","author":"AM Zivkovic","year":"2009","unstructured":"Zivkovic AM, Wiest MM, Nguyen UT, Davis R, Watkins SM, German JB (2009) Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics 5:507. https:\/\/doi.org\/10.1007\/s11306-009-0174-2","journal-title":"Metabolomics"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-018-0971-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-018-0971-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-018-0971-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T14:13:29Z","timestamp":1662732809000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-018-0971-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["971"],"URL":"https:\/\/doi.org\/10.1007\/s00406-018-0971-6","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"22 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol of this study was approved by the Ethics Review Committee on Human Research of the University of Tartu (Estonia). All subjects gave written informed consent in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}